
Strides Pharma Science Limited has informed the Exchange regarding a press release dated May 22, 2025, titled "Strides Delivers strong FY25 Results, Exceeding Outlook Across All Metrics. ".
Filed with NSE ·

Strides Pharma Science Limited has informed the Exchange regarding a press release dated May 22, 2025, titled "Strides Delivers strong FY25 Results, Exceeding Outlook Across All Metrics. ".
6ix hasn’t read this filing yet.
Strides Pharma Science Ltd on 6ix
Follow Strides Pharma Science into a list and get an email when it puts out news.
Follow Strides Pharma Science